Trial intelligence / Profile preview

Domestic vs Imported Clopidogrel Dosage in PCI

NCT03006835Phase 4Unknown

Sponsor
Xijing Hospital
Start
Jan 2017
Primary completion
Dec 2017
Modality
Small Molecules
01

Overview

A Phase 4 trial of clopidogrel in coronary heart disease (CHD), sponsored by Xijing Hospital. Status: unknown.

02

Drugs

clopidogrel
03

Conditions

coronary heart disease (CHD)

Beyond the preview

Go deeper on NCT03006835.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03006835.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call